A detailed history of Prudential Financial Inc transactions in C4 Therapeutics, Inc. stock. As of the latest transaction made, Prudential Financial Inc holds 12,025 shares of CCCC stock, worth $72,150. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,025
Holding current value
$72,150
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$4.05 - $8.1 $48,701 - $97,402
12,025 New
12,025 $55,000
Q4 2021

Feb 14, 2022

SELL
$29.39 - $46.86 $683,905 - $1.09 Million
-23,270 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$35.91 - $50.5 $25,136 - $35,350
700 Added 3.1%
23,270 $1.04 Million
Q2 2021

Aug 16, 2021

SELL
$30.39 - $42.18 $35,556 - $49,350
-1,170 Reduced 4.93%
22,570 $854,000
Q1 2021

May 12, 2021

BUY
$31.96 - $46.5 $758,730 - $1.1 Million
23,740 New
23,740 $879,000

Others Institutions Holding CCCC

About C4 Therapeutics, Inc.


  • Ticker CCCC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,913,800
  • Market Cap $293M
  • Description
  • C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting ...
More about CCCC
Track This Portfolio

Track Prudential Financial Inc Portfolio

Follow Prudential Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.